Introduction
Stem cell therapy has been around long enough to spark curiosity, and unfortunately, a few misconceptions. At American Cell Technology (ACT), we believe that clear, accurate information is key to helping people make informed healthcare decisions. Let’s clear up three of the most common myths we hear.
Myth #1: Stem Cell Therapy Uses Embryonic Stem Cells
Some people associate stem cell therapy with embryonic stem cells, which have been illegal to use in the United States since the 1990s. Modern stem cell therapy at ACT uses only adult stem cells, and in our case, they come directly from you. This means the process is completely ethical and avoids the complex debates tied to embryonic sources.
Myth #2: Donor Stem Cells Are Just as Good
While donor stem cells may be a safe option in certain cases, they always carry a risk of rejection because your body recognizes them as foreign DNA. This can lead to complications ranging from quick elimination of the cells to severe reactions such as graft-versus-host disease (GVHD). With your own banked stem cells, there’s no risk of genetic mismatch, they’re a perfect fit for your body.
Myth #3: Stem Cell Banking Is Too Expensive
Stem cell banking is often seen as unaffordable, but that’s not the case. Initial costs start at just a few thousand dollars, with low yearly storage fees. You only pay when you actually need your cells, and unlike some options abroad, there’s no need for expensive international travel. When compared to the financial and personal toll of surgeries and long recoveries, banking your cells domestically is surprisingly affordable.
Conclusion
Stem cell therapy is advancing quickly, but misinformation can hold people back from exploring its benefits. By understanding the facts, from how the cells are sourced to the actual costs, you can make confident, informed choices about your health and future.
